The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
![](https://webarchive.library.unt.edu/web/20120927070554im_/http://www.cancer.gov/images/spacer.gif)
pazopanib hydrochloride
![Patient Information Patient Information](https://webarchive.library.unt.edu/web/20120927070554im_/http://www.cancer.gov/images/btn-patient-info.gif)
The hydrochloride salt of a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/web/20120927070554im_/http://www.cancer.gov/images/spacer.gif)
US brand name: | ![]() | Votrient | |
![]() | |||
Code name: | ![]() | GW786034B | |
![]() | |||
Chemical structure: | ![]() | 5-((4-((2,3-dimethyl-2h-indazol-6-Yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride | |
![]() |